Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial is a research paper published in International Journal of Infectious Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: 2R37AI054165
National Institute of Allergy and Infectious Diseases
Grant: 75N93019C00050
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI68635
Biomedical Advanced Research and Development Authority
Grant: 75A50120C00034
NIAID NIH HHS
Grant: R37 AI054165
NIAID NIH HHS
Grant: UM1 AI068635
National Institutes of Health
Grant: 3UM1AI068635-17S4
CoVPN 3001 - A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults.
National Institutes of Health
Grant: 5R37AI054165-12
Statistical Methods in HIV Vaccine Efficacy Trials
Administration for Strategic Preparedness and Response
U.S. Department of Health and Human Services
National Institutes of Health
FWCI
2.34
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals